Therefore, the rationale of our study is to evaluate the prevalence of anemia in ESRD-undergoing MHD patients and the correlation between serum Hb levels with raised intact PTH (iPTH > 300 pg/mL) levels and other factors. This evidence concerns the gene GSTM1 and anemia (phenotype).